TCR2 THERAPEUTICS INC's ticker is TCRR and the CUSIP is 87808K106. A total of 84 filers reported holding TCR2 THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $10,622 | -36.4% | 7,081 | -57.6% | 0.00% | – |
| Q4 2022 | $16,691 | -38.2% | 16,711 | +10.8% | 0.00% | – |
| Q3 2022 | $27,000 | -34.1% | 15,076 | +7.6% | 0.00% | – |
| Q2 2022 | $41,000 | -4.7% | 14,010 | -10.8% | 0.00% | – |
| Q1 2022 | $43,000 | +59.3% | 15,707 | +166.7% | 0.00% | – |
| Q4 2021 | $27,000 | -98.9% | 5,889 | -94.8% | 0.00% | -100.0% |
| Q1 2021 | $2,491,000 | +29.3% | 112,795 | +81.2% | 0.01% | +25.0% |
| Q4 2020 | $1,926,000 | +27414.3% | 62,260 | +18540.7% | 0.00% | – |
| Q3 2020 | $7,000 | – | 334 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 6,741,964 | $208,528,000 | 18.01% |
| MPM ASSET MANAGEMENT LLC | 4,050,865 | $125,293,000 | 17.73% |
| Consonance Capital Management LP | 584,885 | $71,268,000 | 6.66% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 136,000 | $4,206,000 | 2.44% |
| Redmile Group, LLC | 2,832,888 | $87,621,000 | 1.06% |
| Altium Capital Management LP | 73,991 | $2,289,000 | 0.86% |
| PFM Health Sciences, LP | 775,794 | $23,995,000 | 0.84% |
| Soleus Capital Management, L.P. | 199,867 | $6,182,000 | 0.82% |
| MOODY ALDRICH PARTNERS LLC | 123,639 | $3,824,000 | 0.62% |
| Sofinnova Investments, Inc. | 333,707 | $10,322,000 | 0.61% |